Christopher Powala was Appointed as President and Chief Executive Officer at NFlection-Therapeutics

Date of management change: June 15, 2019 

What Happened?

Wayne, AB-based NFlection-Therapeutics Appointed Christopher Powala as President and Chief Executive Officer

 

About the Company

NFlection is a biopharmaceutical company focused on the development of novel therapies to address the needs of patients with neurofibromatosis type 1, immunosuppressant-mediated squamous cell carcinoma, and congenital birthmarks such as keratinocytic epidermal nevi and nevus sebaceous.

 

About the Person

Christopher Powala is President and Chief Executive Officer at NFlection Therapeutics. Previously, Christopher held various senior HR leadership roles in the industry.

 

Info Source

News

 

imageShort Profile

 

Name: Christopher Powala

Title: President and Chief Executive Officer

Company: NFlection Therapeutics

Industry: Biotechnology

imageCurrent Contact Info

 

Email: *******@nflectionrx.com 

Phone:.*** 

To get full contact details, please sign in or

 
Your email is safe with us: see our privacy policy
 

Other IT executives who recently changed jobs as well: Demchak Terri, Baker Jill, Wiginton Anthony, Sullivan Mark, McCartney Larry, Falcone Lori, Gregory Emilie, Lacombe Anne, Weil Lowell, Linares Simon, Lee Sang

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.